<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>During the period of May 1986 through February 1991, nine allogeneic bone marrow transplants (BMT) on eight severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) patients were performed at the Instituto Nacional de la Nutrición Salvador Zubirán in Mexico City </plain></SENT>
<SENT sid="1" pm="."><plain>Mean age at BMT was 18 years (age interval 12-30); seven were men; <z:hpo ids='HP_0000001'>all</z:hpo> patients had a clinical history of multiple blood transfusions; six individuals were infected at the time of the transplant </plain></SENT>
<SENT sid="2" pm="."><plain>The conditioning regimens were: <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (Cy) in three patients; Cy+ total nodal radiation in five; and total nodal radiation only in the second transplant of one patient </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">Graft versus host disease</z:e> (GVHD) prophylaxis was attempted with <z:chebi fb="0" ids="44185">methotrexate</z:chebi> plus <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> (CsA) in six patients, <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> plus CsA in two, and <z:chebi fb="0" ids="8382">prednisone</z:chebi> + CsA in the patient retransplanted </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> procedures were carried out under single reverse isolation without gut decontamination </plain></SENT>
<SENT sid="5" pm="."><plain>Seven of the nine procedures grafted (two cases died on days +8 and +25 due to <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>) </plain></SENT>
<SENT sid="6" pm="."><plain>In the surviving, the median time for reaching &gt; 1.0 white blood cells x 10(9)/L was 22 days (time interval 11-31); &gt; 0.5 neutrophils x 10(9)/L in 27 days (time interval 15-42) and the same lapse to reach &gt; 50 platelets x 10(9)/L </plain></SENT>
<SENT sid="7" pm="."><plain>Length of hospital stay was 42 days (time interval 15-61) </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> GVHD was seen in one of the seven patients surviving the period of bone marrow <z:mpath ids='MPATH_58'>aplasia</z:mpath> (14%) </plain></SENT>
<SENT sid="9" pm="."><plain>Of six long term survivors (including one patient with a second transplant) <z:hpo ids='HP_0011010'>chronic</z:hpo> GVHD was present in four (67%): <z:hpo ids='HP_0011010'>chronic</z:hpo> GVHD was fatal in one individual but was well controlled in three.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>